These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24764155)

  • 1. Nodal metastasis and survival in oral cancer: Association with protein expression of SLPI, not with LCN2, TACSTD2, or THBS2.
    Noorlag R; van der Groep P; Leusink FK; van Hooff SR; Frank MH; Willems SM; van Es RJ
    Head Neck; 2015 Aug; 37(8):1130-6. PubMed ID: 24764155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of lymph node density in node-positive patients with oral squamous cell carcinoma.
    Kim SY; Nam SY; Choi SH; Cho KJ; Roh JL
    Ann Surg Oncol; 2011 Aug; 18(8):2310-7. PubMed ID: 21336511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive markers for delayed lymph node metastases and survival in early-stage oral squamous cell carcinoma.
    Luksic I; Suton P
    Head Neck; 2017 Apr; 39(4):694-701. PubMed ID: 28006084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 gene numerical aberration is a predictive marker for occult cervical lymph node metastasis in TNM Stage I and II squamous cell carcinoma of the oral cavity.
    Myo K; Uzawa N; Miyamoto R; Sonoda I; Yuki Y; Amagasa T
    Cancer; 2005 Dec; 104(12):2709-16. PubMed ID: 16265665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of lipocalin 2 and its complex with matrix metalloproteinase-9 in oral cancer.
    Lin CW; Tseng SW; Yang SF; Ko CP; Lin CH; Wei LH; Chien MH; Hsieh YS
    Oral Dis; 2012 Nov; 18(8):734-40. PubMed ID: 22533572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipocalin 2 prevents oral cancer metastasis through carbonic anhydrase IX inhibition and is associated with favourable prognosis.
    Lin CW; Yang WE; Lee WJ; Hua KT; Hsieh FK; Hsiao M; Chen CC; Chow JM; Chen MK; Yang SF; Chien MH
    Carcinogenesis; 2016 Jul; 37(7):712-722. PubMed ID: 27207653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
    Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
    J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
    Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
    Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective validation of the Martinez-Gimeno clinicopathologic scoring system (MGSS) for evaluating risk of cervical lymph node metastases of squamous cell carcinoma of the oral cavity.
    Martínez-Gimeno C; Molinero AP; Castro V; Sastre MJ; Castro EE; Aguirre-Jaime A
    Head Neck; 2005 Apr; 27(4):320-5. PubMed ID: 15700293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of Naa10p associates with lymph node metastasis and predicts favorable prognosis of oral squamous cell carcinoma.
    Zeng Y; Zheng J; Zhao J; Jia PR; Yang Y; Yang GJ; Ma JF; Gu YQ; Xu J
    Tumour Biol; 2016 May; 37(5):6719-28. PubMed ID: 26662107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of copy number profiling in oral and oropharyngeal squamous cell carcinoma.
    van Kempen PM; Noorlag R; Braunius WW; Moelans CB; Rifi W; Savola S; Koole R; Grolman W; van Es RJ; Willems SM
    Cancer Med; 2015 Oct; 4(10):1525-35. PubMed ID: 26194878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative assessment of CD44-mediated depth of invasion as predictor of occult metastases in early oral squamous cell carcinoma.
    Morand GB; Ikenberg K; Vital DG; Cardona I; Moch H; Stoeckli SJ; Huber GF
    Head Neck; 2019 Apr; 41(4):950-958. PubMed ID: 30561155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical nodal stage is a significant predictor of outcome in patients with oral cavity squamous cell carcinoma and pathologically negative neck metastases: results of the international consortium for outcome research.
    Amit M; Yen TC; Liao CT; Binenbaum Y; Chaturvedi P; Agarwal JP; Kowalski LP; Ebrahimi A; Clark JR; Cernea CR; Brandao SJ; Kreppel M; Zöller J; Fliss D; Bachar G; Shpitzer T; Bolzoni VA; Patel PR; Jonnalagadda S; Robbins KT; Shah JP; Patel SG; Gil Z;
    Ann Surg Oncol; 2013 Oct; 20(11):3575-81. PubMed ID: 23775408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy.
    Liao CT; Hsueh C; Lee LY; Lin CY; Fan KH; Wang HM; Huang SF; Chen IH; Kang CJ; Ng SH; Tsao CK; Huang YC; Yen TC
    Oral Oncol; 2012 Apr; 48(4):329-36. PubMed ID: 22104249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression patterns through oral squamous cell carcinoma development: PD-L1 expression in primary tumor and circulating tumor cells.
    Oliveira-Costa JP; de Carvalho AF; da Silveira da GG; Amaya P; Wu Y; Park KJ; Gigliola MP; Lustberg M; Buim ME; Ferreira EN; Kowalski LP; Chalmers JJ; Soares FA; Carraro DM; Ribeiro-Silva A
    Oncotarget; 2015 Aug; 6(25):20902-20. PubMed ID: 26041877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokeratin 19 expression in early oral squamous cell carcinoma and their metastasis: Inadequate biomarker for one-step nucleic acid amplification implementation in sentinel lymph node biopsy procedure.
    Noorlag R; van Es RJJ; de Bree R; Willems SM
    Head Neck; 2017 Sep; 39(9):1864-1868. PubMed ID: 28644540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph node ratio as an independent prognostic factor in oral squamous cell carcinoma.
    Ebrahimi A; Clark JR; Zhang WJ; Elliott MS; Gao K; Milross CG; Shannon KF
    Head Neck; 2011 Sep; 33(9):1245-51. PubMed ID: 20967874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FAS ligand expression in inflammatory infiltrate lymphoid cells as a prognostic marker in oral squamous cell carcinoma.
    Peterle GT; Santos M; Mendes SO; Carvalho-Neto PB; Maia LL; Stur E; Agostini LP; Silva CV; Trivilin LO; Nunes FD; Carvalho MB; Tajara EH; Louro ID; Silva-Conforti AM
    Genet Mol Res; 2015 Sep; 14(3):11145-53. PubMed ID: 26400345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognosis of N2b and N2c lymph node disease in oral squamous cell carcinoma is determined by the number of metastatic lymph nodes rather than laterality: evidence to support a revision of the American Joint Committee on Cancer staging system.
    Ebrahimi A; Gil Z; Amit M; Yen TC; Liao CT; Chaturvedi P; Agarwal JP; Kowalski LP; Kohler HF; Kreppel M; Cernea CR; Brandao J; Bachar G; Bolzoni Villaret A; Fliss D; Fridman E; Robbins KT; Shah JP; Patel SG; Clark JR;
    Cancer; 2014 Jul; 120(13):1968-74. PubMed ID: 24691658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of elective supraomohyoidal neck dissection in the treatment of early, node-negative oral squamous cell carcinoma (OSCC): a retrospective analysis of 122 cases.
    Thiele OC; Seeberger R; Flechtenmacher C; Hofele C; Freier K
    J Craniomaxillofac Surg; 2012 Jan; 40(1):67-70. PubMed ID: 21393009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.